Immunomodulation as a treatment for parkinson's disease in current trials: a systematic review and meta-analysis.
Vega-Angeles, V. T., Morales-Ruiz, V., & Adalid-Peralta, L. V. (2024). Immunomodulation as a treatment for parkinson?s disease in current trials: a systematic review and meta-analysis. Revista de Investigaci?n Cl?nica, 76(3). https://doi.org/10.24875/ric.24000068
ABSTRACT
Immunomodulatory drugs and immunotherapies are being evaluated in clinical trials for the treatment of neuroinflammation, as the latter is an essential mechanism for the development and progression of Parkinson's disease.